510(k) K212819
K212819 is an FDA 510(k) premarket notification submitted by Suzhou Leapmed Healthcare Corporation for the device "Disposable Biopsy Refill Needle". The FDA issued a decision of Substantially Equivalent on Jul 6, 2022. The device falls under product code FCG (Biopsy Needle), a Class II device regulated under 21 CFR 876.1075. Suzhou Leapmed Healthcare Corporation has 3 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jul 6, 2022
- Date Received
- Sep 3, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Biopsy Needle
- Device Class
- Class II
- Regulation Number
- 876.1075
- Review Panel
- GU
- Submission Type
- 510(k)
Need the full FDA record for Suzhou Leapmed Healthcare Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.